Study Site

Chicago, Illinois 75251

1 studies enrolling now · 12 studies all time

What they study most

Acute Major Bleeding, Blood Coagulation Disorders, CKD, Celiac Disease, Congenital Hemophilia A, Hemophilia A, Hereditary Angioedema, Metabolic Acidosis, Seasonal Affective Disorder (SAD), Sickle Cell Anemia, Sickle Cell Disease, Type 2 Diabetes

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis — Recruiting now
• Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes — Completed
• Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease — Completed
• A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 — Completed
• Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A — Completed
• An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A — Completed
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes — Completed
• Prevention of Seasonal Affective Disorder — Completed
• Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus — Completed
• Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks — Completed
• Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy — Completed
• A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. — Completed